These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32510657)

  • 1. The development of outcome key performance indicators for systemic anti-cancer therapy using a modified Delphi method.
    Mellett C; O'Donovan A; Hayes C
    Eur J Cancer Care (Engl); 2020 Jul; 29(4):e13240. PubMed ID: 32510657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of key performance indicators for prehospital emergency care.
    Murphy A; Wakai A; Walsh C; Cummins F; O'Sullivan R
    Emerg Med J; 2016 Apr; 33(4):286-92. PubMed ID: 26796739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Canadian evaluation framework for quality improvement in childhood arthritis: key performance indicators of the process of care.
    Barber CEH; Twilt M; Pham T; Currie GR; Benseler S; Yeung RSM; Batthish M; Blanchette N; Guzman J; Lang B; LeBlanc C; Levy DM; O'Brien C; Schmeling H; Soon G; Spiegel L; Whitney K; Marshall DA
    Arthritis Res Ther; 2020 Mar; 22(1):53. PubMed ID: 32192528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of key performance indicators for medication management services provided for outpatients.
    Lima TM; Aguiar PM; Storpirtis S
    Res Social Adm Pharm; 2019 Sep; 15(9):1080-1087. PubMed ID: 30262211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing guideline-based key performance indicators for recurrent miscarriage care: lessons from a multi-stage consensus process with a diverse stakeholder group.
    Hennessy M; Linehan L; Dennehy R; Devane D; Rice R; Meaney S; O'Donoghue K
    Res Involv Engagem; 2022 May; 8(1):18. PubMed ID: 35568920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of key performance indicators to evaluate centralized intake for patients with osteoarthritis and rheumatoid arthritis.
    Barber CE; Patel JN; Woodhouse L; Smith C; Weiss S; Homik J; LeClercq S; Mosher D; Christiansen T; Howden JS; Wasylak T; Greenwood-Lee J; Emrick A; Suter E; Kathol B; Khodyakov D; Grant S; Campbell-Scherer D; Phillips L; Hendricks J; Marshall DA
    Arthritis Res Ther; 2015 Nov; 17():322. PubMed ID: 26568556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing key performance indicators for a tertiary children's hospital network.
    Elliot C; Mcullagh C; Brydon M; Zwi K
    Aust Health Rev; 2018 Sep; 42(5):491-500. PubMed ID: 30122160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of key performance indicators to capture in measuring the impact of pharmacists in caring for patients with epilepsy in primary healthcare: A Delphi consensual study.
    Shawahna R
    Epilepsy Behav; 2019 Sep; 98(Pt A):129-138. PubMed ID: 31374468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of key performance indicators for emergency departments in Ireland using an electronic modified-Delphi consensus approach.
    Wakai A; O'Sullivan R; Staunton P; Walsh C; Hickey F; Plunkett PK
    Eur J Emerg Med; 2013 Apr; 20(2):109-14. PubMed ID: 22382650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Achieving consensus on priority items for paediatric palliative care outcome measurement: Results from a modified Delphi survey, engagement with a children's research involvement group and expert item generation.
    Coombes L; Harðardóttir D; Braybrook D; Scott HM; Bristowe K; Ellis-Smith C; Fraser LK; Downing J; Bluebond-Langner M; Murtagh FE; Harding R
    Palliat Med; 2023 Dec; 37(10):1509-1519. PubMed ID: 37853579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of clinical pharmacy key performance indicators for hospital pharmacists using a modified Delphi approach.
    Fernandes O; Gorman SK; Slavik RS; Semchuk WM; Shalansky S; Bussières JF; Doucette D; Bannerman H; Lo J; Shukla S; Chan WW; Benninger N; MacKinnon NJ; Bell CM; Slobodan J; Lyder C; Zed PJ; Toombs K
    Ann Pharmacother; 2015 Jun; 49(6):656-69. PubMed ID: 25780250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of quality indicators for the organization of palliative care: a modified RAND Delphi study in seven European countries (the Europall project).
    Woitha K; Van Beek K; Ahmed N; Jaspers B; Mollard JM; Ahmedzai SH; Hasselaar J; Menten J; Vissers K; Engels Y
    Palliat Med; 2014 Feb; 28(2):121-9. PubMed ID: 23861161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Practical Test of Quality Indicators for Palliative Care in Patients With Chronic Heart Failure.
    Hamatani Y; Takada Y; Miyamoto Y; Kawano Y; Anchi Y; Shibata T; Suzuki A; Nishikawa M; Ito H; Kato M; Shiga T; Fukumoto Y; Izumi C; Yasuda S; Ogawa H; Sugano Y; Anzai T
    Circ J; 2020 Mar; 84(4):584-591. PubMed ID: 31983725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population-Based Quality Indicators for Palliative Care Programs for Cancer Patients in Japan: A Delphi Study.
    Nakazawa Y; Kato M; Yoshida S; Miyashita M; Morita T; Kizawa Y
    J Pain Symptom Manage; 2016 Apr; 51(4):652-661. PubMed ID: 26674609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and Prioritization of Quality Indicators for Conservative Kidney Management.
    Harrison TG; Tam-Tham H; Hemmelgarn BR; James MT; Sinnarajah A; Thomas CM
    Am J Kidney Dis; 2019 Feb; 73(2):174-183. PubMed ID: 30482578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developing key performance indicators for prescription medication systems.
    Spackman E; Clement F; Allan GM; Bell CM; Bjerre LM; Blackburn DF; Blais R; Hazlewood G; Klarenbach S; Nicolle LE; Persaud N; Alessi-Severini S; Tierney M; Wijeysundera HC; Manns B
    PLoS One; 2019; 14(1):e0210794. PubMed ID: 30645647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring the quality of a childhood cancer care delivery system: assessing stakeholder agreement.
    Bradley NM; Robinson PD; Greenberg ML; Barr RD; Klassen AF; Chan YL; Greenberg CM
    Value Health; 2013 Jun; 16(4):639-46. PubMed ID: 23796299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensity of end-of-life health care and mortality after systemic anti-cancer treatment in patients with advanced lung cancer.
    Oselin K; Pisarev H; Ilau K; Kiivet RA
    BMC Cancer; 2021 Mar; 21(1):274. PubMed ID: 33722202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Key performance indicators for pharmaceutical services: A systematic review.
    de Souza JFF; Fernandes BD; Rotta I; Visacri MB; de Mendonça Lima T
    Explor Res Clin Soc Pharm; 2024 Jun; 14():100441. PubMed ID: 38665264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thirty-day mortality after systemic anticancer treatment as a real-world, quality-of-care indicator: the Northland experience.
    Ang E; Newton LV
    Intern Med J; 2018 Apr; 48(4):403-408. PubMed ID: 28872748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.